Acrospire Investment Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-1,600
Closed -$140K 623
2017
Q2
$140K Buy
1,600
+200
+14% +$16.9K 0.13% 95
2017
Q1
$125K Sell
1,400
-2,300
-62% -$192K 0.1% 194
2016
Q4
$274K Buy
3,700
+1,700
+85% +$127K 0.11% 180
2016
Q3
$151K Buy
2,000
+100
+5% +$7.66K 0.1% 270
2016
Q2
$146K Buy
1,900
+500
+36% +$39.5K 0.11% 207
2016
Q1
$109K Buy
+1,400
New +$97.8K 0.08% 268

Other funds holding HCA

Acrospire Investment Management's HCA Position: Q3 2017 in Review

Acrospire Investment Management sold out of HCA Healthcare (HCA) in Q3 2017, closing a stake of 1,600 shares — an estimated $140K sold.

Acrospire Investment Management first reported a position in HCA in Q1 2016 and held it in 6 quarters. The position peaked at $274K in Q4 2016. 529 funds tracked by Wall St. Rank hold HCA as of Q3 2017.

  • Acrospire Investment Management reported no remaining HCA Healthcare position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,600 HCA Healthcare shares in Q3 2017, an estimated $140K.
  • Acrospire Investment Management first reported a position in HCA Healthcare in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's HCA Healthcare position peaked at $274K in Q4 2016.
  • 529 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.